期刊文献+

老年肝硬化患者血清胱抑素水平的检测价值 被引量:2

下载PDF
导出
摘要 目的 为探讨血清胱抑素在肝硬化患者肾功损害的应用价值。方法  18例健康对照及 5 8例肝硬化患者(Child -Pugh积分分组 :A级 12例 ,B级 18例 ,C级 2 8例 ) ,同时标本采样检测Ccr ;留取 2 4h尿液标本 ,同时采静脉血 3ml ,分别检测血肌酐尿肌酐 ,并换算内生肌酐清除率 ,换算公式 :Ccr =[尿肌酐浓度 (μmol/L)×尿流量 (ml/min)× 1.73 (m2 ) ] /[血肌酐 (μmol/L)×体表面积 (m2 ) ]。设备 :日丽 760 0 0 10型全自动生化分析仪 ,及德灵全自动特定蛋白 (Bnprospec分析 )分析仪 ,血cys .C采用Behring免疫散射比浊法。结果 A/B/C血胱抑素均比正常组高 ,四组cys .C检测值有显著性差异 (P <0 .0 5 )。用相关性分析肝硬化病人血清胱抑素C与Ccr异常之间有显著负相关 (r = 0 .43 3 ,t=4.13 (76) 0 .0 1,P <0 .0 1)。结论 胱抑素测定是反映肝病患者的肾功能状况良好且快速简便的指标。
机构地区 绵阳市中心医院
出处 《四川医学》 CAS 2005年第2期150-151,共2页 Sichuan Medical Journal
基金 20 0 0年四川省卫生厅科研项目 (0 2 0 0 89)
  • 相关文献

参考文献8

  • 1邬露丹,卢文波,吴巧萍.测定肾小球滤过率的理想标志物—胱抑素C[J].宁波医学,2000,12(10):471-472. 被引量:11
  • 2王笑云 陈文彬.常用肾脏功能实验检测,诊断学[M](第6版)[M].北京:人民卫生出版社,2004.379-380.
  • 3胡芙蓉,张永铭.血清胱抑素C的测定及其临床应用[J].实验与检验医学,2001,23(6):375-377. 被引量:30
  • 4张淑兰,王铭超,李青果,冯忠军.胱抑素C的临床应用及进展[J].国外医学(临床生物化学与检验学分册),2002,23(5):271-272. 被引量:69
  • 5Ylinen EA,AIa Houhala M,Harmonen AP, et al.Cystatin C as a marker for glomerular filtration rate in pediatric patients [ J ]. Pediatr Nephrol,1999,13(6) :506 - 509.
  • 6Filex,G,Prien F,Vollmer, 1, et al.Diagnostic sensifivty of serum cystatin for impaired glomerular filtration rat[J] .Pedialri :Nephrol, 1999,13(6) :501 - 505.
  • 7Rainer,PW, Birgit SW, et al. Corcelation of serum concentration of cystic C and creatinine to inulin clearance in liver cirrhosis[J]. Clin Chem,2000,46(5):713 -715.
  • 8Rainer PW, Birgit SW, et al. Correlation of serum concentration of cystin C and creatinine to inulin clearance in liver cirrhosis[ J ]. Clin Chem, 2000,46:713 - 715.

二级参考文献31

  • 1[1]Shemesh O, Golbetz H, et al. Limitations of creatinine as a filtration marker in glomerulopathic patients[J]. Kidney Int, 1985;28:830~838.
  • 2[2]Perrone RD, Madias NE, et al. Serum creatinine as an index of renal function: new insights into old concepts [J]. Clin Chem,1992;38:1933~1953.
  • 3[3]Jacobsson B, Lignelid H, et al. Transthyretin and cyststin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas [J].Histopathology, 1995; 16:559~564.
  • 4[4]Abrahamson M, Olafsson I, et al. Structure and expression of the human cystatin C gene[J]. Biochem J,1990;268:287~294.
  • 5[5]Grubb A, Simonsen O, et al. Serum concentratuon of cystatin C,factor D and β2-microglobulin as a measure of glomerular filtration rate[M]. Acta Med Scand, 1985;218:499~503.
  • 6[6]Kyhse Andersen J, Schmidt C, et al. Serum cystatin C,determined by a rapid, automated particle -enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate[J]. Clin Chem, 1994;40:1921~1926.
  • 7[7]Finney H, Newman DJ, et al. Initial evaluation of cystatin C measurement by particleenhanced immunonephelometry on the Behring nephelometer systems (BNA.BN Ⅱ )[J]. Clin Chem,1997;43:1016~1022.
  • 8[8]Newman DJ, Thakkar H, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine[J]. Kidney Int,1995;47:312~318.
  • 9[9]Helin I, Axenram M, et al. Serum cystatin C as a deleminant of glomerular filtration rate in children[J]. Clin Nephrol,1998;49:221~225.
  • 10[10]Mitch WE, Walser M. Nutritional therapy for the uremic patient in: Brenner BM(ed) The Kidney. W.B.Saunders Company [M]. Philadelphia.pp,2382~2423.

共引文献104

同被引文献17

  • 1蔡钢强,垢敬,焦连亭.胱抑素C的生物学特性及临床应用评价[J].国际检验医学杂志,2006,27(5):457-460. 被引量:57
  • 2俸家富,凊植光,冯凯祥,曾平,向礼贤,张建辉,章静.半胱氨酸蛋白酶抑制剂C对肝硬化患者肾功能早期损害的实验评价[J].检验医学,2006,21(3):234-237. 被引量:3
  • 3黄荣宁,谭晓明,易小敏,赖伟忠.肝硬化患者血清胱抑素水平检测结果分析[J].医学信息(西安上半月),2006,19(11):2006-2007. 被引量:2
  • 4黄哑 石娟娟 忻鼎 等.血清半胱氨酸蛋白酶抑制物C,肾功能的敏感指标.上海医学检验杂志,2001,16(5):425-431.
  • 5Gerbes AL, Gulberg V, Bilzer M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver[ H ]. Gut ,2002,50( 1 ) :106 - 110.
  • 6托马斯.临床实验诊断学[M].上海:上海科学技术出版社,2004.617.
  • 7Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function[J]. Clin Chem l.ab Med, 1999,37 (4):389 395.
  • 8Mussap M,Dalla VM,Fioretto P,et al. Cystatin C is a more sensi rive marker than ereatinine for the estimation of GFR in type 2 di abetic patients[J]. Kindney Int, 2002,61 (13) " 1453-1461.
  • 9Djian MC, Blanchet B, Pesce F, et a. Comparison of the time to extubation after use of remifentanil or sufentanil in combination with propofol as anesthesia in aduhs undergoing nonemergency [J]. Clin Ther,2006,28(4) :560 568.
  • 10Filer G,Prierl F, VollmerI, et al. Diagnostic sensitivity of serum cystatin for Inpaired glomerular filtration rate[J]. Pediatr Neph rol, 1999,13(6) : 505-510.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部